poisar

Stocks · News reference

Goldman Sachs Adjusts Rocket Lab Price Target to $68

Fiscal.ai

Goldman Sachs has maintained a 'Hold' rating on Rocket Lab while increasing its price target from $67 to $68.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. The Motley FoolJames Brumley

    Rocket Lab's Stock Price Keeps Falling While Its Revenue and Backlog Keep Growing. Which Trend Should Investors Trust?

    Rocket Lab's fundamentals are strengthening with 73% revenue growth, 52% backlog increase, and $1 billion in new launch contracts, yet its stock remains down 50% from May peaks due to repeated delays of its Neutron rocket. Despite investor frustration, analysts maintain a strong buy rating with a $96.80 price target, suggesting the disconnect between operational performance and stock price may eventually resolve as the company proves itself.

  2. The Motley FoolLeo Sun

    Rocket Lab Says Adjusted EBITDA Turns Positive Within 6 Months of Neutron’s First Flight. Here’s the Date That Implies.

    Rocket Lab claims its adjusted EBITDA will turn positive within six months of its Neutron rocket's first successful flight, expected in early 2027. The company has repeatedly delayed the Neutron launch since 2021, but analysts project positive $41 million adjusted EBITDA in 2027 compared to negative $55 million in 2026, driven by removing development expenses and accessing a larger commercial market.

  3. The Motley FoolBrett Schafer

    Here's What $1,000 in Each of These 3 Space Stocks Could Be Worth by 2030

    The article analyzes three space economy stocks as potential investment opportunities by 2030. SpaceX dominates the launch market with strong Starlink and AI infrastructure growth. Rocket Lab is positioning itself as a competitive alternative with its Neutron vehicle and satellite acquisitions. Planet Labs offers satellite imaging services with strong revenue growth. All three stocks are high-risk, high-growth investments trading at steep valuations that require perfect execution to deliver multibagger returns.

  4. The Motley FoolDaniel Sparks

    Rocket Lab Hit 100 Launches Faster Than Any Other Commercially Developed Rocket. I'd Buy a Small Stake.

    Rocket Lab achieved its 100th Electron rocket launch faster than any other commercially developed rocket, demonstrating reliable operations with 96 successful launches and a growing backlog of 117 missions. However, the analyst recommends only a small position, as the company's profitability depends on Neutron, a much larger rocket not expected to launch until 2027. With a $40 billion valuation and negative EBITDA, the stock trades at over 45 times sales, making it a speculative bet on future performance.

  5. The Motley FoolDavid Jagielski, Cpa

    Down 60% From Its 52-Week High, Is Rocket Lab Stock a Bargain Buy?

    Rocket Lab stock has plummeted 60% from its 52-week high, but the company posted impressive Q3 results with 73% revenue growth and a $3.6 billion backlog. Despite operating losses, positive cash flow and the milestone of 100 Electron rocket launches show promise. However, delays to the Neutron rocket launch until 2027 have discouraged investors. The stock trades at a lower valuation than SpaceX, potentially offering growth investors an intriguing opportunity if the Neutron launch succeeds.

  6. The Motley FoolJake Lerch

    Rocket Lab Doesn’t Have to Become the Next SpaceX. Here’s What It Does Have to Deliver.

    Rocket Lab should not be compared to SpaceX as they operate in different markets with different capabilities. While Rocket Lab's Neutron rocket development is promising, the company faces execution challenges and high valuation expectations. Success requires profitable operations, on-schedule launches, and a series of successful Neutron missions starting in 2027. The stock's P/S ratio of 46 leaves little room for setbacks.